UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Damage associated molecular pattern molecules

Clinical immunology (Orlando, Fla.), 2007-07, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

Methods for delivery of adenoviral vectors to tumor vasculature

Human gene therapy, 2007-02, Vol.18 (2), p.151-160

2007

Volltextzugriff (PDF)

Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells

Human pathology, 2007-07, Vol.38 (7), p.1047-1056

2007

Volltextzugriff (PDF)

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

Clinical pharmacology and therapeutics, 2018-10, Vol.104 (4), p.742-748

2018

Volltextzugriff (PDF)

International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

Cancer Immunology, Immunotherapy, 2006-11, Vol.55 (11), p.1406-1411

2006

Volltextzugriff (PDF)

Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test

Archives of pharmacal research, 2004-06, Vol.27 (6), p.633-639

2004

Volltextzugriff (PDF)

Determination of Similarity Margin in Comparative Clinical Studies to Support the Development of Biosimilar Products of Neupogen® (Filgrastim, Granulocyte Colony-Stimulating Factor [G-CSF])

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2018-08, Vol.32 (4), p.325-330

2018

Volltextzugriff (PDF)

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

Cancer Immunology, Immunotherapy, 2009-12, Vol.58 (12), p.1949-1957

2009

Volltextzugriff (PDF)

FOCiS on Damage Associated Molecular Pattern Molecules

Clinical immunology (Orlando, Fla.), 2007-04, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged : Imapct of aging on cancer immunity and immunotherapy

Cancer immunology and immunotherapy, 2009, Vol.58 (12), p.1949-1957

2009

Volltextzugriff (PDF)

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

Human gene therapy, 2004-07, Vol.15 (7), p.637-647

2004

Volltextzugriff (PDF)

Conformational Change of p53 Protein in Growth Factor-Stimulated Human Myelogenous Leukemia Cells

Leukemia & lymphoma, 1994, Vol.14 (3-4), p.251-255

1994

Volltextzugriff (PDF)

Recombinant Adenoviral Vector Containing Tumor-Specific L-Plastin Promoter Fused to Cytosine Deaminase Gene as a Transcription Unit: Generation and Functional Test

Archives of pharmacal research, 2004, Vol.27 (6), p.633-639

2004

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology

The American journal of medicine, 1996-03, Vol.100 (3), p.299-307

1996

Volltextzugriff (PDF)

Recent advances in the application of gene therapy to human disease

The American Journal of Medicine, 1995-11, Vol.99 (5), p.537-552

1995

Volltextzugriff (PDF)

Ad-sig-TAA/CD40L Vector Prime-TAA/CD40L Protein Boost Vaccine for Epithelial Neoplasms

Journal of immunotherapy (1997), 2005-11, Vol.28 (6), p.638

2005

Volltextzugriff (PDF)

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

The American journal of medicine, 1979-08, Vol.67 (2), p.194-200

1979

Volltextzugriff (PDF)

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors

Human gene therapy, 1997-07, Vol.8 (11), p.1321-1330

1997

Volltextzugriff (PDF)

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

Transplantation, 1996-12, Vol.62 (12), p.1806

1996

Volltextzugriff (PDF)

Systemic Treatment Of Malignant Melanoma

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.463-474

2000

Volltextzugriff (PDF)

The use of chemotherapy resistance in cancer treatment

The cancer journal from Scientific American, 1997-03, Vol.3 (2), p.60

1997

Volltextzugriff (PDF)

Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Ovarian Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, Texas

Human gene therapy, 1994-12, Vol.5 (12), p.1507-1522

1994

Volltextzugriff (PDF)

Hematopoietic Retroviral Gene Marking in Patients with Follicular Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 1999, Vol.32 (3-4), p.279-288

1999

Volltextzugriff (PDF)

Use of a Retroviral Vector to Study the Trafficking Patterns of Purified Ovarian Tumor Infiltrating Lymphocytes (TIL) Used in Intraperitoneal Adoptive Immunotherapy of Ovarian Cancer Patients. A Pilot Study. University of Texas M.D. Anderson Cancer Center, Houston, Texas

Human gene therapy, 1996-07, Vol.7 (11), p.1351-1365

1996

Volltextzugriff (PDF)

Adult Leukemia

Journal of occupational and environmental medicine, 1990-04, Vol.32 (4), p.381

Deisseroth, Albert B.

1990

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(79)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(49)
Science & Technology
(49)
Humans
(46)
Animals
(17)
Oncology
(17)
Female
(15)
Biological And Medical Sciences
(13)
Genetics & Heredity
(10)
Male
(10)
Medical Sciences
(10)
Medicine, Research & Experimental
(10)
Middle Aged
(10)
Research & Experimental Medicine
(10)
Adult
(9)
Immunology
(9)
Base Sequence
(8)
Biochemistry & Molecular Biology
(8)
Molecular Sequence Data
(8)
Biotechnology & Applied Microbiology
(7)
Bone Marrow Transplantation
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Damage associated molecular pattern molecules

Methods for delivery of adenoviral vectors to tumor vasculature

Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test

Determination of Similarity Margin in Comparative Clinical Studies to Support the Development of Biosimilar Products of Neupogen® (Filgrastim, Granulocyte Colony-Stimulating Factor [G-CSF])

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

FOCiS on Damage Associated Molecular Pattern Molecules

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged : Imapct of aging on cancer immunity and immunotherapy

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

Conformational Change of p53 Protein in Growth Factor-Stimulated Human Myelogenous Leukemia Cells

Recombinant Adenoviral Vector Containing Tumor-Specific L-Plastin Promoter Fused to Cytosine Deaminase Gene as a Transcription Unit: Generation and Functional Test

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology

Recent advances in the application of gene therapy to human disease

Ad-sig-TAA/CD40L Vector Prime-TAA/CD40L Protein Boost Vaccine for Epithelial Neoplasms

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

Systemic Treatment Of Malignant Melanoma

The use of chemotherapy resistance in cancer treatment

Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Ovarian Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, Texas

Hematopoietic Retroviral Gene Marking in Patients with Follicular Non-Hodgkin's Lymphoma

Use of a Retroviral Vector to Study the Trafficking Patterns of Purified Ovarian Tumor Infiltrating Lymphocytes (TIL) Used in Intraperitoneal Adoptive Immunotherapy of Ovarian Cancer Patients. A Pilot Study. University of Texas M.D. Anderson Cancer Center, Houston, Texas

Adult Leukemia

Aktive Filter

Suchergebnisse filtern